Ignite Creation Date:
2025-12-24 @ 7:44 PM
Ignite Modification Date:
2026-01-29 @ 6:42 AM
Study NCT ID:
NCT03783403
Status:
TERMINATED
Last Update Posted:
2024-09-19
First Post:
2018-12-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPĪ±, in Participants With Advanced Solid and Hematologic Cancers
Sponsor:
Celgene
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CC-95251-ST-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None